HRP20170416T1 - Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba - Google Patents
Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba Download PDFInfo
- Publication number
- HRP20170416T1 HRP20170416T1 HRP20170416TT HRP20170416T HRP20170416T1 HR P20170416 T1 HRP20170416 T1 HR P20170416T1 HR P20170416T T HRP20170416T T HR P20170416TT HR P20170416 T HRP20170416 T HR P20170416T HR P20170416 T1 HRP20170416 T1 HR P20170416T1
- Authority
- HR
- Croatia
- Prior art keywords
- platinum
- reaction mixture
- pyrophosphate
- substituted
- monomer complex
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261651200P | 2012-05-24 | 2012-05-24 | |
| PCT/US2013/031885 WO2013176764A1 (en) | 2012-05-24 | 2013-03-15 | Synthetic and purification methods for phosphaplatin compounds and uses thereof |
| EP13793812.2A EP2855496B1 (en) | 2012-05-24 | 2013-03-15 | Synthetic and purification methods for phosphaplatin compounds and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20170416T1 true HRP20170416T1 (hr) | 2017-05-19 |
Family
ID=49624225
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20170416TT HRP20170416T1 (hr) | 2012-05-24 | 2013-03-15 | Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba |
| HRP20191904TT HRP20191904T1 (hr) | 2012-05-24 | 2019-10-21 | Postupak pročišćavanja spojeva fosfaplatine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20191904TT HRP20191904T1 (hr) | 2012-05-24 | 2019-10-21 | Postupak pročišćavanja spojeva fosfaplatine |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8846964B2 (enExample) |
| EP (2) | EP2855496B1 (enExample) |
| JP (1) | JP5833795B2 (enExample) |
| CN (2) | CN106967124B (enExample) |
| CY (2) | CY1118746T1 (enExample) |
| DK (2) | DK3202769T3 (enExample) |
| ES (2) | ES2619412T3 (enExample) |
| HR (2) | HRP20170416T1 (enExample) |
| HU (2) | HUE032197T2 (enExample) |
| IN (1) | IN2014KN02722A (enExample) |
| LT (2) | LT3202769T (enExample) |
| PL (2) | PL3202769T3 (enExample) |
| PT (2) | PT3202769T (enExample) |
| RS (2) | RS59725B1 (enExample) |
| SI (2) | SI3202769T1 (enExample) |
| SM (2) | SMT201700168T1 (enExample) |
| TW (2) | TWI599361B (enExample) |
| WO (1) | WO2013176764A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT201700168T1 (it) * | 2012-05-24 | 2017-05-08 | Phosplatin Therapeutics Llc | Metodi di sintesi e di purificazione per composti di fosfaplatino e utilizzi degli stessi |
| TWI798175B (zh) * | 2016-04-06 | 2023-04-11 | 美商弗斯普萊汀治療股份有限公司 | 磷酸鉑(phosphaplatin)液態調配物 |
| US10668080B2 (en) | 2017-01-06 | 2020-06-02 | Phosplatin Therapeutics Llc | Phosphaplatin compounds as therapeutic agents for treatment of bone or blood cancers |
| JP7381083B2 (ja) * | 2017-09-08 | 2023-11-15 | フォスプラティン テラピューティクス インコーポレイテッド | 免疫調節剤としてのホスファプラチン化合物およびその治療的使用 |
| CN113861036B (zh) * | 2021-11-08 | 2024-04-02 | 合肥工业大学 | 一种乙二胺高氯酸铜配合物的制备及用途 |
| US11673904B1 (en) * | 2021-12-09 | 2023-06-13 | L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Low pressure process for synthesis of Pt(PF3)4 involving a soluble intermediate and storage of obtained Pt(PF3)4 |
| CN119822568B (zh) * | 2025-02-19 | 2025-08-19 | 扬州宏鑫环保科技有限公司 | 一种高效纯化水制备装置及制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4234500A (en) | 1979-03-07 | 1980-11-18 | Engelhard Minerals & Chemicals Corporation | Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes |
| JP4463274B2 (ja) | 2003-06-27 | 2010-05-19 | 明 小谷 | ビスホスホネート錯体 |
| RU2008135369A (ru) * | 2006-01-30 | 2010-03-10 | Платко Текнолоджис (Проприэтэри) Лимитед (Za) | Получение комплексов платины(ii) |
| RU2482841C2 (ru) * | 2007-05-18 | 2013-05-27 | ТиТиАй Эллебо, Инк. | Устройства для трансдермальной доставки, обеспечивающие улучшенное высвобождение действующего начала через биологическую поверхность |
| DK2173337T3 (da) * | 2007-08-06 | 2014-09-15 | Univ Ohio | Phosphaplatiner og deres anvendelse i behandlingen af cancer, der er resistent over for cisplatin og carboplatin |
| SI2575802T1 (sl) * | 2010-06-04 | 2017-03-31 | Ohio University | Fosfaplatini in njihova uporaba za zdravljenje raznih vrst raka |
| EP2763537B1 (en) * | 2011-10-05 | 2018-01-10 | Rathindra N. Bose | Efficient processes for large scale preparation of phosphaplatins antitumor agents |
| SMT201700168T1 (it) * | 2012-05-24 | 2017-05-08 | Phosplatin Therapeutics Llc | Metodi di sintesi e di purificazione per composti di fosfaplatino e utilizzi degli stessi |
-
2013
- 2013-03-15 SM SM20170168T patent/SMT201700168T1/it unknown
- 2013-03-15 WO PCT/US2013/031885 patent/WO2013176764A1/en not_active Ceased
- 2013-03-15 PT PT162038517T patent/PT3202769T/pt unknown
- 2013-03-15 PL PL16203851T patent/PL3202769T3/pl unknown
- 2013-03-15 LT LT16203851T patent/LT3202769T/lt unknown
- 2013-03-15 LT LTEP13793812.2T patent/LT2855496T/lt unknown
- 2013-03-15 RS RS20191364A patent/RS59725B1/sr unknown
- 2013-03-15 JP JP2015514010A patent/JP5833795B2/ja active Active
- 2013-03-15 SM SM20190617T patent/SMT201900617T1/it unknown
- 2013-03-15 ES ES13793812.2T patent/ES2619412T3/es active Active
- 2013-03-15 PL PL13793812T patent/PL2855496T3/pl unknown
- 2013-03-15 CN CN201710071127.6A patent/CN106967124B/zh active Active
- 2013-03-15 EP EP13793812.2A patent/EP2855496B1/en active Active
- 2013-03-15 SI SI201331598T patent/SI3202769T1/sl unknown
- 2013-03-15 HR HRP20170416TT patent/HRP20170416T1/hr unknown
- 2013-03-15 IN IN2722KON2014 patent/IN2014KN02722A/en unknown
- 2013-03-15 DK DK16203851T patent/DK3202769T3/da active
- 2013-03-15 SI SI201330565A patent/SI2855496T1/sl unknown
- 2013-03-15 HU HUE13793812A patent/HUE032197T2/en unknown
- 2013-03-15 PT PT137938122T patent/PT2855496T/pt unknown
- 2013-03-15 ES ES16203851T patent/ES2751668T3/es active Active
- 2013-03-15 CN CN201380026289.8A patent/CN104540839B/zh active Active
- 2013-03-15 HU HUE16203851A patent/HUE046327T2/hu unknown
- 2013-03-15 DK DK13793812.2T patent/DK2855496T3/en active
- 2013-03-15 EP EP16203851.7A patent/EP3202769B1/en active Active
- 2013-03-15 RS RS20170272A patent/RS55806B1/sr unknown
- 2013-04-01 TW TW102111669A patent/TWI599361B/zh active
- 2013-04-01 TW TW106122720A patent/TWI653237B/zh active
- 2013-09-20 US US14/032,704 patent/US8846964B2/en active Active
-
2014
- 2014-03-18 US US14/217,883 patent/US8859796B1/en active Active
-
2017
- 2017-03-13 CY CY20171100317T patent/CY1118746T1/el unknown
-
2019
- 2019-10-21 HR HRP20191904TT patent/HRP20191904T1/hr unknown
- 2019-11-21 CY CY20191101227T patent/CY1122316T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20170416T1 (hr) | Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba | |
| HRP20140808T1 (hr) | Fosfaplatine i njihova uporaba za lijeäśenje raka rezistentnog na cisplantin i karboplatin | |
| HRP20201847T1 (hr) | Postupak za pripremu spoja diariltiohidantoina | |
| CN102481513A (zh) | 用于气体吸着的离子液体和装置的使用方法 | |
| JP2014154178A5 (enExample) | ||
| ES2531396T3 (es) | Proceso para preparar compuestos de piridinona | |
| HRP20180976T1 (hr) | Inhibitori iap | |
| AR048008A1 (es) | Procesos para la preparacion de inhibidores de caspasa derivados de los mismos | |
| CN103951582A (zh) | 一种乙酰乙酰苯胺类化合物的制备方法 | |
| CN102531989B (zh) | 一种（s）-奥拉西坦的纯化方法 | |
| TW201706035A (zh) | 逆滲透膜用洗淨劑、洗淨液及洗淨方法 | |
| CN104058981A (zh) | 一种门冬氨酸鸟氨酸的制备方法 | |
| WO2013079507A3 (de) | Verfahren zur herstellung und aufreinigung von salzen der acrylamido-2-methyl-propansulfonsäure | |
| WO2006047575A3 (en) | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents | |
| CN103254660B (zh) | 一种不含尿素的二磺酸三嗪基类荧光增白剂液体的制备方法 | |
| CN102531988A (zh) | 一种左旋奥拉西坦的纯化方法 | |
| HRP20180948T1 (hr) | Postupak za proizvodnju aminokiselinskih spojeva | |
| CN105037288B (zh) | 一种布醇的制备方法 | |
| AR081267A1 (es) | Procedimiento de obtencion de la forma cristalina a del febuxostat | |
| CN103316566A (zh) | 一种醇胺和三氟甲磺酸碱金属盐复配溶液、制备方法与应用 | |
| HRP20140942T1 (hr) | Postupak pripreme kontrastnih sredstava | |
| RU2009128063A (ru) | Способ получения и выделения отдельных стереоизомеров 1-амино, 3-замещенных фенилциклопентанекарбоксилатов | |
| CN102976881B (zh) | 一种联苯的制备方法 | |
| JP6126102B2 (ja) | 純粋なＳ−（−）−９−フルオロ−６，７−ジヒドロ−８−（４−ヒドロキシピペリジン−１−イル）−５−メチル−１−オキソ−１Ｈ，５Ｈ−ベンゾ［ｉ，ｊ］キノリジン−２−カルボン酸Ｌ−アルギニン塩４水和物およびその製造方法 | |
| HRP20140839T1 (hr) | Postupak sinteze ivabradina i njegovih adicijskih soli i farmaceutski prihvatljivih kiselina |